179 related articles for article (PubMed ID: 18043446)
1. Immunogenicity and safety of a pneumococcal conjugate 7-valent vaccine in infants with sickle cell disease.
Reinert P; Benkerrou M; de Montalembert M; Lesprit E; Abadie I; Bernaudin F; Doit C; Bingen E; Tetelboum R; Bonnet E
Pediatr Infect Dis J; 2007 Dec; 26(12):1105-9. PubMed ID: 18043446
[TBL] [Abstract][Full Text] [Related]
2. Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM(197) among infants with sickle cell disease. Pneumococcal Conjugate Vaccine Study Group.
O'Brien KL; Swift AJ; Winkelstein JA; Santosham M; Stover B; Luddy R; Gootenberg JE; Nold JT; Eskenazi A; Snader SJ; Lederman HM
Pediatrics; 2000 Nov; 106(5):965-72. PubMed ID: 11061761
[TBL] [Abstract][Full Text] [Related]
3. Tolerability and immunogenicity of an eleven valent mixed carrier Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid or tetanus protein conjugate vaccine in Finnish and Israeli infants.
Dagan R; Kayhty H; Wuorimaa T; Yaich M; Bailleux F; Zamir O; Eskola J
Pediatr Infect Dis J; 2004 Feb; 23(2):91-8. PubMed ID: 14872172
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of a heptavalent pneumococcal conjugate vaccine in Apache and Navajo Indian, Alaska native, and non-native American children aged <2 years.
Miernyk KM; Parkinson AJ; Rudolph KM; Petersen KM; Bulkow LR; Greenberg DP; Ward JI; Brenneman G; Reid R; Santosham M
Clin Infect Dis; 2000 Jul; 31(1):34-41. PubMed ID: 10913393
[TBL] [Abstract][Full Text] [Related]
5. Primary and booster salivary antibody responses to a 7-valent pneumococcal conjugate vaccine in infants.
Choo S; Zhang Q; Seymour L; Akhtar S; Finn A
J Infect Dis; 2000 Oct; 182(4):1260-3. PubMed ID: 10979930
[TBL] [Abstract][Full Text] [Related]
6. The pneumococcal conjugate vaccine.
Jacobson RM; Poland GA
Minerva Pediatr; 2002 Aug; 54(4):295-303. PubMed ID: 12131865
[TBL] [Abstract][Full Text] [Related]
7. Comparison of an opsonophagocytic assay and IgG ELISA to assess responses to pneumococcal polysaccharide and pneumococcal conjugate vaccines in children and young adults with sickle cell disease.
Vernacchio L; Romero-Steiner S; Martinez JE; MacDonald K; Barnard S; Pilishvili T; Carlone GM; Ambrosino DM; Molrine DC
J Infect Dis; 2000 Mar; 181(3):1162-6. PubMed ID: 10720547
[TBL] [Abstract][Full Text] [Related]
8. Long-term antibody levels and booster responses in South African children immunized with nonavalent pneumococcal conjugate vaccine.
Huebner RE; Mbelle N; Forrest B; Madore DV; Klugman KP
Vaccine; 2004 Jul; 22(21-22):2696-700. PubMed ID: 15246599
[TBL] [Abstract][Full Text] [Related]
9. Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant.
Wuorimaa T; Dagan R; Väkeväinen M; Bailleux F; Haikala R; Yaich M; Eskola J; Käyhty H
J Infect Dis; 2001 Nov; 184(9):1211-5. PubMed ID: 11598848
[TBL] [Abstract][Full Text] [Related]
10. [Serious invasive pneumococcal disease in young children: the importance of vaccination].
Haveman LM; Geelen SP; Sanders EA; Wolfs TF
Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1917-20. PubMed ID: 12404904
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine as a booster dose in 12- to 18-month-old children primed with 3 doses of 7-valent pneumococcal conjugate vaccine.
Thisyakorn U; Chokephaibulkit K; Kosalaraksa P; Benjaponpitak S; Pancharoen C; Chuenkitmongkol S
Hum Vaccin Immunother; 2014; 10(7):1859-65. PubMed ID: 25424793
[TBL] [Abstract][Full Text] [Related]
12. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children.
Kilpi T; Ahman H; Jokinen J; Lankinen KS; Palmu A; Savolainen H; Grönholm M; Leinonen M; Hovi T; Eskola J; Käyhty H; Bohidar N; Sadoff JC; Mäkelä PH;
Clin Infect Dis; 2003 Nov; 37(9):1155-64. PubMed ID: 14557958
[TBL] [Abstract][Full Text] [Related]
13. Serum opsonic activity in infants with sickle-cell disease immunized with pneumococcal polysaccharide protein conjugate vaccine. The Pneumococcal Conjugate Vaccine Study Group.
Nowak-Wegrzyn A; Winkelstein JA; Swift AJ; Lederman HM
Clin Diagn Lab Immunol; 2000 Sep; 7(5):788-93. PubMed ID: 10973456
[TBL] [Abstract][Full Text] [Related]
14. Revaccination with polyvalent pneumococcal vaccine in children with sickle cell anemia.
Kaplan J; Sarnaik S; Schiffman G
Am J Pediatr Hematol Oncol; 1986; 8(1):80-2. PubMed ID: 3717518
[TBL] [Abstract][Full Text] [Related]
15. Immunisation with a pneumococcal 7-valent conjugate vaccine.
Dagan R
Int J Clin Pract; 2002 May; 56(4):287-91. PubMed ID: 12074212
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection.
Nachman S; Kim S; King J; Abrams EJ; Margolis D; Petru A; Shearer W; Smith E; Moye J; Blanchard S; Hawkins E; Bouquin P; Vink P; Benson M; Estep S; Malinoski F;
Pediatrics; 2003 Jul; 112(1 Pt 1):66-73. PubMed ID: 12837869
[TBL] [Abstract][Full Text] [Related]
17. 7-valent pneumococcal conjugate vaccine: new preparation. Prevents rare invasive infections in infants.
Prescrire Int; 2002 Feb; 11(57):7-10. PubMed ID: 11985376
[TBL] [Abstract][Full Text] [Related]
18. [The safety and immunogenicity of an heptavalent pneumococcal polysaccharide conjugate vaccine (Prevenar) administered in association with a whole-cell pertussis-based pediatric combination vaccine (DTP-IPV/PRP-T) to French infants with a two-, three-, and four-month schedule].
Reinert P; Guy M; Girier B; Szelechowski B; Baudoin B; Deberdt P; Wollner A; Kemeny G; Amzallag M; Moat C; Szelechowski C; Villain-Lemoine H; Bouhanna CA; Laudat F
Arch Pediatr; 2003 Dec; 10(12):1048-55. PubMed ID: 14643532
[TBL] [Abstract][Full Text] [Related]
19. Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine.
Nurkka A; Ahman H; Korkeila M; Jäntti V; Käyhty H; Eskola J
Pediatr Infect Dis J; 2001 Jan; 20(1):25-33. PubMed ID: 11176563
[TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants.
Rennels MB; Edwards KM; Keyserling HL; Reisinger KS; Hogerman DA; Madore DV; Chang I; Paradiso PR; Malinoski FJ; Kimura A
Pediatrics; 1998 Apr; 101(4 Pt 1):604-11. PubMed ID: 9521941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
